Summary of opinion: Bluevac BTV (previously known as Bluevac BTV8), 22/05/2024 Positive
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 21-22 May 2024
Human medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 14, Status: Authorised
Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions
List of centrally authorised products requiring a notification of a change for update of annexes
Clinical Trials Information System (CTIS): Walk-in clinic - May 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 May 2024, 16:00 (CEST) to 15 May 2024, 17:00 (CEST)
IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
Environmental Risk Assessment (ERA) Assessors Training, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 23 May 2024, 13:00 (CEST) to 24 May 2024, 14:00 (CEST)
Veterinary medicines European public assessment report (EPAR): Strangvac, Streptococcus equi vaccine (recombinant proteins), Status: Authorised
Herbal medicinal product: Rhodiolae roseae rhizoma et radixArray, F: Assessment finalised